Radiosurgical Management of Brain Metastases

Stereotactic radiosurgery (SRS) has been established as an excellent treatment option for a large subset of patients with metastatic brain disease. Evidence-based practice guidelines have recently been published attempting to consolidate the wide variety of data available regarding when and how to implement SRS in the comprehensive treatment of this heterogeneous patient population. Although class I evidence is sparse in the current literature, many effective treatment paradigms have evolved centered around SRS.